News Classic

The U.S. stock market erupted with gains following Donald Trump‘s victory in the 2024 presidential election and a potential Republican sweep of Congress. This sets the stage for what some analysts call a new “Roaring 2020s.”

The S&P 500 — tracked by the SPDR S&P 500 ETF Trust SPY — jumped 2.5% to fresh record highs on Wednesday, marking its best one-day performance in nearly two years and the strongest ever in a post-Election day.

Analysts and investors speculate that Trump’s planned corporate tax cuts and deregulation could fuel a prolonged rally in the stock market.

Notably, small-cap stocks, represented by the iShares Russell 2000 ETF Trust IWM, surged 5.8%, reflecting investor optimism that domestic-focused companies could benefit most from protectionist policies expected under Trump’s administration.

Chart: Small Caps Jump Nearly 6% After Election Day

Read Also: Goldman Sachs Predicts Bleak Long-Term S&P 500 Returns As Market Concentration Hits ‘Highest Level In 100 Years’

A ‘Roaring 2020s’ Market Rally?

Veteran Wall Street investor Ed Yardeni described this post-election surge as “consistent with a Roaring 2020s scenario.” Yardeni believes that Trump’s policies could increase the odds of robust economic growth, strong corporate earnings, and an extended bull market.

“Stocks soared today on the widespread perception that Trump 2.0 will include a cut in the corporate tax rate and reductions in business regulations,” Yardeni wrote in a note on Thursday.

According to Yardeni, the conditions are shaping up for an economic boom similar to the 1920s — a period of rapid economic growth, technological advancement, and soaring stock prices.

But the economic boom of the 1920s eventually led to a stock market crash in 1929 and the onset of the Great Depression.

Yardeni draws a parallel, quoting Mark Twain: “History doesn’t repeat itself, but it often rhymes.”

The expert assigns a 50% probability to the “Roaring 2020s” scenario, a 20% probability to a “1990s-style stock market meltup,” and a 30% chance of a “1970s-style geopolitical crisis with a possible U.S. debt crisis.”

Yardeni also indicates that he is considering increasing the probability of the Roaring 2020s scenario, given the likelihood of a more business-friendly environment under Trump.

How High Could The S&P 500 Go?

Yardeni has bold projections for the S&P 500 if the “Roaring 2020s” scenario materializes.

He estimates an average annual return of around 11% for the S&P 500, including reinvested dividends.

This forecast sharply contrasts with the one presented by Goldman Sachs last month, where analysts at the investment bank predicted a decade of modest gains for stocks, with the S&P 500 averaging just 3% annually over the next 10 years.

In Yardeni’s view, stocks remain the best hedge against inflation, as companies can often pass on higher costs to consumers.

Under his “Roaring 2020s” scenario, strong productivity growth and stable inflation rates could bolster corporate profits and sustain the market’s upward trajectory.

Yardeni expects the S&P 500 could climb to 8,000 by the end of the decade, driven largely by rising corporate earnings rather than inflated valuation multiples.

Read now:

Wilmington, Delaware, United States, Transparency Market Research, Inc. , Nov. 07, 2024 (GLOBE NEWSWIRE) — The global potato protein market was projected to attain US$ 209.6 million in 2022. It is anticipated to garner a 6.9% CAGR from 2023 to 2031 and by 2031 the market is likely to attain US$ 381.5 million by 2031.

Leading companies in the market are making significant investments to advance the development of potato extract proteins and enhance the production process. In an effort to produce a fully plant-based product, the industry is moving toward using plant-based stabilizers and emulsifiers because of the growing consumer awareness of food additives and allergies.

Download Sample PDF Copy of the Potato Protein Market Research Summary Now –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36767

As political unrest and climate change disrupt the supply chains for protein resources and threaten food security, plant-based proteins like those found in potatoes will become increasingly important to our future.

Global Potato Protein Market: Key Players

Prominent producers are concentrating on the ethical and sustainable source of potatoes. This can be attributed to growing concerns over foodstuffs, particularly proteins used in cooking, coming from sources free of animal cruelty and that practice.

To satisfy the growing demand from the profitable vegan food and sports nutrition industries, vendors are also making major investments in the production of potato extract proteins and tuberous crop proteins. The following companies are well-known participants in the global potato protein market:

• Tereos
• Avebe U.A.
• AGRANA Beteiligungs-AG
• Roquette Frères S. A.
• Bioriginal Food and Science Corp.
• Duynie Group
• Kemin Industries Inc.
• Meelunie B.V.
• KMC Kartoffelmelcentralen A.M.B.A
• Lyckeby Starch AB
• AKV Langholt AmbA
• Emsland Group
• Kerry Group
• PPZ SA Niechlów
• PEPEES S.A

Key Findings of the Market Report

• The potato protein market is being driven by an increasing trend toward clean-label products and sustainable dietary alternatives.
• Potato proteins are popular healthy snack substitutes for typical snacks since they are used as components in dairy products, nutritious bars, and meat substitutes.
• The market for potato protein is in line with changing customer preferences, and producers in the food and beverage industry are attempting to include it in a range of snacks.
• Commercial plant protein synthesis is a relatively new development in food technology, and more work has to be done to lower the cost of and increase public accessibility to potato-based proteins.
• Potato protein is becoming more and more popular as a main ingredient in animal feed and nutritious bars, two profitable and well-liked possibilities.

Market Trends for Potato Protein

• The food and beverage sector has to incorporate agents that are used in foaming, emulsification, and gelling. For the technology and food services industries, it is imperative that synthetic versions of these chemicals be replaced. Agents derived from potatoes provide special qualities such improved taste, texture, and product stability.
• The growing awareness of consumers towards food allergies and additives is propelling market growth. Suppliers are moving toward using the adaptable qualities of potato protein in their dairy, bread, and nutritious goods. In addition to fundamental components like plant- or dairy-based proteins, a report published in the Journal of Food Science claims that protein bars contain a sizable quantity of additional tastes and stabilizers.
• Stabilizers and additives made from potato protein are becoming more popular as companies in the food industry work to produce products which are entirely plant-based.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36767

Global Market for Potato Protein: Regional Outlook

Various reasons are propelling the growth of potato protein throughout the region. These are:

• In 2022, Asia Pacific held the majority of the global market share for potato protein. Market statistics are being driven by greater consumer awareness of food allergies and increased uptake of plant-based protein in the area.
• In the long run, plant-based proteins help populous nations like China and India strengthen their efforts towards food security as they adjust to supply chain disruptions brought on by climate change.
• Europe held a prominent position in the global scene in 2022. Due to the prevalence of potatoes, the continent accounts for the a significant share of the global potato production and consumption.
• A major movement toward veganism and a healthy diet among the younger population, along with better government rules, is expected to promote market growth.

Some key developments by the players in this market are:

• PerfectaSOL, a new line of potato products, was introduced in December 2023 by Avebe, a provider of ingredients based on potatoes located in the Netherlands. This substance can be utilized for confections, alternative dairy, and other culinary items. The innovative product has emulsification, smoothness, neutral white hue, and smoothness.
• The distribution business Brenntag and Avebe announced their partnership in July 2023. As a result, Brenntag would distribute Avebe’s goods, including protein components and potato starch, across Turkey.

Global Potato Protein Market Segmentation

Form

End Use

• Meat Alternatives
• Plant Based Dairy Products
• Nutritional Bars
• Others

Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

Discover the untapped potential of the Potato Protein Market! Unlock valuable information about each segment. Place your order now- https://www.transparencymarketresearch.com/checkout.php?rep_id=36767&ltype=S

More Trending Report by Transparency Market Research:

• Probiotics Market – The global probiotics market is estimated to flourish at a CAGR of 8.0% from 2023 to 2031.
• Curcumin Market – The global curcumin market was estimated at US$ 362.0 million in 2022. A CAGR of 6.7% is anticipated from 2023 to 2031, resulting in US$ 608.2 million in 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

New York, United States , Nov. 07, 2024 (GLOBE NEWSWIRE) — “Cell therapy” refers to the process of administering live cells to patients with the purpose of treating various diseases. Both autologous and allogeneic cells, which can be produced from stem cells found in places like bone marrow, can serve as the source of the cell. The treatment of bone marrow transplant patients often involves stem cell therapy. In the context of medical practice, “gene therapy” refers to any procedure that modifies, deletes, or otherwise alters a patient’s genetic code. In addition, it can change the way a person’s genes are expressed or fix genes that aren’t functioning properly. In this treatment, nucleic acid (DNA or RNA) is given to the patient together with carriers that are referred to as vectors.

Download Free Sample Report PDF @ https://straitsresearch.com/report/cell-and-gene-therapy-market/request-sample 

Market Dynamics

Investing More in Pharmaceutical Research and Development

The majority of pharmaceutical companies continue to make significant investments in the development of new medications and equipment. The pharmaceutical business, in particular, is heavily invested in research and development. Pharmaceutical firms spend on research and development in order to bring high-quality, innovative goods to market. The trend implies that major pharma companies are enhancing their R&D efficiency by investing heavily in R&D in order to obtain long-term returns on their investment, as well as through collaborating on R&D.

Increase in the Incidence of Cancer and Heart Diseases

Cell therapy targets various diseases at the cellular level, such as by restoring a certain cell population or by using cells as carriers of the therapeutic carriers, whereas gene therapy aims to influence the course of various genetic and acquired disorders at the genetic level. Gene therapies also aim to treat inherited disorders as well as acquired ones. It is anticipated that the high incidence of cardiovascular illness would accelerate demand for cell and gene therapy, which will in turn fuel the growth of the market.

Clinical Studies for Cell and Gene Therapy Are Becoming More Common

Clinical tests are an essential component of medical research, and they provide assistance to the pharmaceutical and biopharmaceutical industries in their efforts to develop and bring innovative cell and gene treatments to market. Due to the increased need for innovative medications to satisfy unmet medical requirements, there has been a worldwide increase in the number of clinical trials that have been conducted during the past several years.

Regional Analysis

The North American cell and gene therapy market is driven by the region’s high economic position as well as the region’s high spending on healthcare services. Sponsorship and financial support for cell and gene therapy products come mostly from national health institutions, companies, academic institutes, and hospitals respectively.

To Gather Additional Insights on the Regional Analysis of the Cell And Gene Therapy Market @ https://straitsresearch.com/report/cell-and-gene-therapy-market/request-sample

Key Highlights

• The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, expanding at a CAGR of 22.7% from 2025 to 2033.

• An increase in the prevalence of cancer will drive the market.
• Investing in Pharmaceutical R&D will fuel the market growth.
• The global market is segmented into the following categories: type, indication, application, end user, and by region.
• Based on product type, the market for cell and gene therapy market is divided into two categories: cell therapy and gene therapy. In this market in the year 2020, the most significant share was held by cell therapy.
• Based on application the cell and gene therapy market is segmented into: Oncology, Dermatology, Musculoskeletal and others. The need for solutions including cell and gene therapy will be driven by factors such as the growing use of target gene treatments for dermatological conditions, the increasing demand for wound healing, and the treatment of burnt skin.
• Based on end-user the cell and gene therapy market is divided into Pharmaceuticals and Biotechnologies companies, academic and research institutes and other end users. It is anticipated that the section representing pharmaceutical and biotechnology firms would record the greatest CAGR by the end of the projected period in the year 2020.
• The North American cell and gene therapy market is driven by the region’s high economic position as well as the region’s high spending on healthcare services.

Competitive Players

1. Thermo Fisher Scientific (US)
2. Merck KGaA (Germany)
3. Charles River Laboratories (US)
4. Lonza (Switzerland)
5. Catalent (US)
6. WuXi AppTec (China)
7. Takara Bio Inc. (Japan)
8. Nikon Corporation (Japan)
9. FUJIFILM Holdings Corporation (Japan)
10. F. Hoffmann-La Roche Ltd. (Switzerland)
11. Oxford Biomedica plc (UK)
12. Cell and Gene Therapy Catapult (UK)

Recent Developments

• In 2021, Charles River Laboratories expanded its cell and gene therapy manufacturing capabilities by purchasing Cognate BioServices, a contract manufacturing organization (CMO) specializing in cell and gene therapy.
• Thermo Fisher Scientific paid roughly USD 859.7 million to buy Henogen S.A. in 2021. Henogen S.A. was the viral vector production company that Novasep operated in Belgium. Through this purchase, it will be able to strengthen its position in the manufacturing therapeutic market for cell and gene therapies.
• In 2019, Thermo Fisher Scientific spent $1.7 billion to purchase Brammer Bio, a firm whose primary business was the production of viral vectors for use in gene and cell treatments.

Segmentation

1. By Therapy Type
   1. Cell therapy
      1. CAR-T
      2. CAR-NK
      3. B-Cell
      4. Other
   2. Gene Therapy
      1. Viral
      2. Non-Viral
2. By Region
   1. North America
   2. Europe
   3. APAC
   4. LAMEA

Get Detailed Market Segmentation @ https://straitsresearch.com/report/cell-and-gene-therapy-market/segmentation 

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (U.S.)

+91 8087085354 (India)

+44 203 695 0070 (U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Wilmington, Delaware, United States, Transparency Market Research Inc. , Nov. 07, 2024 (GLOBE NEWSWIRE) — The global human papillomavirus vaccine market (سوق لقاحات فيروس الورم الحليمي البشري) was projected to attain US$ 4 billion in 2022. It is anticipated to garner a 9.4% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 9.1 billion by 2031.

Human papillomavirus (HPV) is a widespread virus that affects many different regions of the body. Over two hundred viruses make up the HPV category, of which over forty types are transmitted during intercourse. Sexually transmitted infections (STIs) such as HPV that affect the genitalia are often spread through physical contact.

Request Sample PDF Report: Empower Your Industry Understanding with Invaluable Insights-https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37085

Throughout the forecast period, a rise in government efforts is anticipated to support the size of the global market for human papillomavirus vaccines. The creation of new compounds that target HPV presents market participants with profitable potential. To get a larger market share, manufacturers are heavily investing in the creation of novel HPV vaccinations for all age groups.

Global Human Papillomavirus Vaccine Market: Key Players

The primary objective of major companies is to enhance the efficiency of the adult human papillomavirus vaccination by investing in research and development and launching new products.

These firms are pursuing profitable revenue prospects by staying up to date with the newest developments in the human papillomavirus vaccine industry. The following companies are well-known participants in the global human papillomavirus vaccine market:

• Merck & Co. Inc.
• GlaxoSmithKline plc
• Sanofi
• AstraZeneca
• Serum Institute of India Pvt. Ltd.
• Xiame Innovax Biotech CO. LTD.
• General Incorporated Foundation
• Chemo-Sero-Therapeutic Research Institute (Kaketsuken)
• Bharat Biotech

Key Findings of the Market Report

• To stop the spread of the human papillomavirus, governments everywhere are launching a number of campaigns and efforts for the creation and distribution of HPV vaccinations.
• Global distribution of HPV vaccinations as well as screening and immunization programs are funded by both private and public entities.
• According to a January 2023 Vaccines Journal article, Switzerland completely funds the HPV vaccination for girls between the ages of 15 and 26 and for boys between the ages of 11 and 14.

Market Trends for Human Papillomavirus Vaccine Market

• The most prevalent sexually transmitted infection (STI) globally is HPV. It is believed that 80% of those who engage in sexual activity have had HPV infection at some point in their life. Over the course of the projection period, an increase in the incidence of HPV-related illnesses such as vaginal, anal, and cervical cancer is anticipated to support demand for the human papillomavirus vaccines globally.
• Cervical cancer is the second most common disease among Indian women, and the second most common among women aged 15 to 44, according to the HPV and Related Cancers report 2023. According to the same source, India diagnoses 123,907 women with cervical cancer annually.

Global Market for Human Papillomavirus Vaccine: Regional Outlook

Various reasons are propelling the growth of human papillomavirus vaccine throughout the region. These are:

• In terms of global market share for human papillomavirus vaccines in 2022, North America held the majority of the share. This is attributed to the population’s increased incidence of cervical cancer and other HPV-related malignancies as well as the enhanced healthcare infrastructure.
• In the United States, 9,440 new cases of anal cancer were discovered in 2022, according to research released by the American Cancer Society. Furthermore, 1,450 Canadian women had a cervical cancer diagnosis in 2022, according to the Canadian Cancer Society.
• An article in the Human Vaccine and Immunotherapeutic Journal from February 2023 states that HPV vaccinations in the United States can begin as early as age nine and continue until age 26.
• Approximately 77% of teens, aged 13 to 17 have gotten one or more doses of the HPV vaccination, with roughly 62% completing the whole series. The human papillomavirus vaccine market is anticipated to develop significantly in the area due to significant coverage for the HPV vaccination and early screening programs.

Unlock Growth Potential in Your Industry! Download PDF Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37085

Some key developments by the players in this market are:

• To begin a cervical cancer screening program in India, Roche Diagnostics India and the Cancer Awareness Prevention and Early Detection Trust (CAPED) signed a Memorandum of Understanding (MoU) in March 2023.
• Health Canada approved the expanded use of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in April 2022 for people 9 to 45 years old in order to protect against infection with Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58. Merck Canada received this approval.

Global Human Papillomavirus Vaccine Market Segmentation

Valence

• Bivalent
• Quadrivalent and Nonavalent

Indication

• Cervical Cancer
• Anal Cancer
• Vaginal Cancer
• Penile Cancer
• Vulvar Cancer
• Oropharyngeal Cancer
• Genital Warts
• Others

Distribution Channel

• Physicians
• Wholesalers
• Physician Distributors
• Government Entities
• Public and Private Alliances

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights https://www.transparencymarketresearch.com/checkout.php?rep_id=37085&ltype=S

More Trending Report by Transparency Market Research:

• Vaccines Market – The global vaccines market (سوق اللقاحات) was estimated at a value of US$ 119.1 billion in 2022. It is anticipated to register a 4.2% CAGR from 2022 to 2031 and by 2031, the market is likely to attain US$ 99.3 billion by 2031.
• Neurotoxin Market – The global neurotoxin market (سوق السموم العصبية) stood at US$ 7.78 billion in 2023 and is projected to reach US$ 13.3 billion in 2031. The global neurotoxin market is anticipated to expand at a CAGR of 6.8% between 2023 and 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube